Plex Research
Plex Research, Inc. is a biotechnology company leveraging a revolutionary focal graph approach, combining knowledge graphs and centrality algorithms, to revolutionize biomedical research and drug discovery. Their AI-driven platform, AutoPlex, can autonomously plan, execute, and interpret large-scale research campaigns, uncovering novel discoveries with verifiable experimental data and transparent methodologies. The platform handles diverse data formats, including omics, clinical studies, scientific literature, and chemical structures, processing close to one billion data points. Plex aims to make scientific data findable, accessible, searchable, and transparent, enabling biopharmaceutical companies to accelerate drug discovery pipelines, identify novel drug targets, new disease indications, patient selection biomarkers, and perform safety assessments. They offer solutions through their AI-driven search platform and scientific services on a quarterly or annual basis, or through strategic partnerships leveraging their autonomous discovery capabilities. The company was founded by Douglas Selinger and is based in Cambridge, MA.
Plex Research
Plex Research, Inc. is a biotechnology company leveraging a revolutionary focal graph approach, combining knowledge graphs and centrality algorithms, to revolutionize biomedical research and drug discovery. Their AI-driven platform, AutoPlex, can autonomously plan, execute, and interpret large-scale research campaigns, uncovering novel discoveries with verifiable experimental data and transparent methodologies. The platform handles diverse data formats, including omics, clinical studies, scientific literature, and chemical structures, processing close to one billion data points. Plex aims to make scientific data findable, accessible, searchable, and transparent, enabling biopharmaceutical companies to accelerate drug discovery pipelines, identify novel drug targets, new disease indications, patient selection biomarkers, and perform safety assessments. They offer solutions through their AI-driven search platform and scientific services on a quarterly or annual basis, or through strategic partnerships leveraging their autonomous discovery capabilities. The company was founded by Douglas Selinger and is based in Cambridge, MA.